Finoriq research workspace
Zhengye Biotechnology Holding Ltd (ZYBT) SEC Filings & Filing Highlights
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale. Review ZYBT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
- Company
- Zhengye Biotechnology Holding Ltd (ZYBT)
- Ticker
- ZYBT
- Market Cap
- $291.5M
- Latest Price
- $6.15
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.